4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)(1,1'-biphenyl)-2-sulfonamide,
BMS 346567,
BMS-346567,
BMS346567,
sparsentan,
254740-64-2,
RE-021,
UNII-9242RO5URM,
PS433540,
Sparsentan (RE-021),
PS-433540,
9242RO5URM,
CHEMBL539423,
BMS-346567,
retrophin,
Sparsentan [USAN],
compound 7 [PMID 15634011],
PS 33540,
Sparsentan(PS433540),
SCHEMBL535109,
GTPL8448,
BCP23969,
BDBM50175523,
CS-7947,
DB12548,
SB16876,
DARA-a (Dual Acting Receptor Antagonist of angiotension and endothelin receptors),
HY-17621,
L023324,
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide,
4''''-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-2''''-ethoxymethyl-biphenyl-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-amide,
4''-(2-Butyl-4-oxo-1,3-diaza-spiro[4.4]non-1-en-3-ylmethyl)-2''-ethoxymethyl-biphenyl-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-amide,
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide,
D05PYP,
D0YS1U,
C32H40N4O5S,
RE 201,
CID10257882,
CID 10257882,
4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-n-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide,